Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death

被引:74
作者
Simmons, Z [1 ]
机构
[1] Penn State Coll Med, Dept Neurol, Hershey, PA 17033 USA
关键词
amyotrophic lateral sclerosis; quality of life; palliative care; hospice; end-of-life care;
D O I
10.1097/01.nrl.0000178758.30374.34
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disorder that is inevitably fatal. There are no effective treatments to stop or reverse the natural course of the disease. The role of the physician is to provide comfort and optimize quality of life. Review Summary: Management of patients with ALS is a process extending over months to years. It begins with breaking the news of the diagnosis and extends through the terminal phase. Medication may extend lifespan by a small amount. However, most efforts are centered around symptom management. Areas of importance include respiration, nutrition, secretions, communication, pseudobulbar affect, therapy and exercise, spasticity and cramps, pain, depression and suicide, spirituality and religion, cognitive changes, the development of advance directives, and care at the end of life. Multidisciplinary ALS clinics provide much-needed support for patients with ALS and their caregivers. Conclusion: Although physicians cannot cure ALS or even halt progression, there is much that can be done to manage the physical and emotional symptoms, thereby maintaining or enhancing quality of life.
引用
收藏
页码:257 / 270
页数:14
相关论文
共 203 条
[71]   A CRITICAL-APPRAISAL OF THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS [J].
GILL, TM ;
FEINSTEIN, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (08) :619-626
[72]   Correlates of quality of life in people with motor neuron disease (MND) [J].
Goldstein, LH ;
Atkins, L ;
Leigh, PN .
AMYOTROPHIC LATERAL SCLEROSIS, 2002, 3 (03) :123-129
[73]   SURGICAL MANAGEMENT OF SIALORRHEA [J].
GOODE, RL ;
SMITH, RA .
LARYNGOSCOPE, 1970, 80 (07) :1078-&
[74]   Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis [J].
Gordon, PH ;
Moore, DH ;
Gelinas, DF ;
Qualls, C ;
Meister, ME ;
Werner, J ;
Mendoza, M ;
Mass, J ;
Kushner, G ;
Miller, RG .
NEUROLOGY, 2004, 62 (10) :1845-1847
[75]   MOTOR NEURON DISEASE IN THE PROVINCE OF FERRARA, ITALY, IN 1964-1982 [J].
GRANIERI, E ;
CARRERAS, M ;
TOLA, R ;
PAOLINO, E ;
TRALLI, G ;
ELEOPRA, R ;
SERRA, G .
NEUROLOGY, 1988, 38 (10) :1604-1608
[76]   Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival [J].
Gregory, S ;
Siderowf, A ;
Golaszewski, AL ;
McCluskey, L .
NEUROLOGY, 2002, 58 (03) :485-487
[78]   Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familiar amyotrophic lateral sclerosis [J].
Gurney, ME ;
Cutting, FB ;
Zhai, P ;
Doble, A ;
Taylor, CP ;
Andrus, PK ;
Hall, ED .
ANNALS OF NEUROLOGY, 1996, 39 (02) :147-157
[79]   Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis [J].
Harriman, M ;
Morrison, M ;
Hay, J ;
Revonta, M ;
Eisen, A ;
Lentle, B .
JOURNAL OF OTOLARYNGOLOGY, 2001, 30 (04) :242-245
[80]   ALS patients on TPPV - Totally locked-in state, neurologic findings and ethical implications [J].
Hayashi, H ;
Oppenheimer, EA .
NEUROLOGY, 2003, 61 (01) :135-137